Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
We're back up, so people can leave comments after these posts, register, etc.
The plan is to move over the all of the post content to the GRACE website, and then start a new forum section there, freezing the OncTalk forums so that they can be read and searched, but not added to. Instead, a very similar forum structure has been started in the GRACE website, separated by "verticals", so that questions about drug side effects can be attended to not only by me and Dr. Laskin but also Dr. McCune, a Pharm D, radiation oncology questions can be fielded by expert radiation oncologist Dr. Vivek Mehta, and other questions can be covered by the most qualified expert(s). The division by subject will also exist with the articles/blog content the faculty provide, so people can find multiple posts about radiation oncology or social work/coping with cancer all together.
I expert that there will be some tweaking to do once we move, so please provide your suggestions. We can always continue to improve it.
But expect that sometime in the next week or so you'll be directed over to the posts at GRACE instead of OncTalk, and from the OncTalk discussion forum to the forum at GRACE to add new entries. Please jump in when the time comes. We will likely auto-redirect the web browsers at some point in the future, once the kinks are ironed out (most, at least).
Please feel free to offer comments and raise questions in our
discussion forums.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.